Disney, DirecTV agree to restore programming, B+L mulls sale: Morning Buzz

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

• Disney (DIS) and DirecTV (T) reached an agreement to restore programming for 11M viewers
• Alcoa (AA) announced an agreement to sell a 25.1% stake in Ma’aden JV to Ma’aden
• Demand for Apple’s (AAPL) iPhone 16 Pro is lower than expected, according to analyst Ming Chi-Kuo
• Bausch + Lomb (BLCO) is mulling a sale, FT reports
• Intel (INTC) reached a $3.5B deal to make chips for the U.S. military, Bloomberg says

2. WALL STREET CALLS:

• Wedbush upgraded Zillow (ZG) to Outperform, raised price target to $80
• Wells downgraded Colgate (CL) to Underweight with growth normalizing
• Yelp (YELP) initiated with bearish view at BofA
• BioNTech (BNTX) was upgraded at JPMorgan and saw its price target raised by $25 at BofA, here’s why
• Ally Financial (ALLY) downgraded to Neutral at BTIG

3. AROUND THE WEB:

• StoneCo (STNE) is putting Linx up for sale three years after buying the asset, Exame reports
• Indian antitrust regulator CCI found Amazon (AMZN) and Walmart’s (WMT) Flipkart violated local competition laws, Reuters reports
• Citigroup (C) is shifting responsibility for part of its compliance work and around 800 employees from Chief Operating Officer Anand Selva after the bank was fined $136M by regulators for reporting failures, FT says
• Boeing (BA) may need to pursue a “mega” equity raise as the way to shore up liquidity while its worker strike drags on, FT suggests
• Top officials in Berlin were not briefed in advance about an invitation for UniCredit (UNCRY) to bid for a German government stake in Commerzbank (CRZBY), FT reports

4. MOVERS:

• Nuvalent (NUVL) gains after highlighting the presentation of updated data from the Phase 1 dose-escalation portions of the ongoing ARROS-1 Phase ½ trial of zidesamtinib
• Ascendis Pharma (ASND) increases in New York after announcing data from its ApproaCH trial of TransCon CNP
• Gevo (GEVO) higher after announcing the U.S. Patent and Trademark Office, PTO, granted a patent for its ethanol to olefins process
• iTeos Therapeutics (ITOS) lower after announcing interim data from its GALAXIES Lung-201
• Vizsla Silver (VZLA) falls in New York after announcing a $65M bought deal financing

5. EARNINGS/GUIDANCE:

• ImmunoPrecise (IPA) reported Q1 results, with EPS missing consensus
• ModivCare (MODV) cut its guidance for FY24
• Coffee Holding (JVA) reported Q3 results, with EPS higher year-over-year
• Canoo (GOEV) provided guidance for September and withdrew its previously-issued revenue guidance for FY24
• Coda Octopus (CODA) announced Q3 results, with CEO Annmarie Gayle commenting, “Management continues to focus on growing the company while continuing to demonstrate that we run a solid and profitable business year-on-year”

INDEXES:

Near midday, the Dow was up 140.93, or 0.34%, to 41,534.71, the Nasdaq was down 153.69, or 0.87%, to 17,530.29, and the S&P 500 was down 8.88, or 0.16%, to 5,617.14.